English
简体中文
Total: £ 56.28
Published Date: 2025-07-09 | Pages: 81 | Tables: 84 | Pharma & Healthcare
The global market for Cobamamide for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cobamamide is mainly used for megaloblastic anemia, malnutrition anemia, pregnancy anemia, polyneuritis, radiculopathy, trigeminal neuralgia, sciatica, nerve palsy, it can also be used for nutritional disorders, radiation, and drug-induced leukopenia.
North American market for Cobamamide for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cobamamide for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cobamamide for Injection include Haerbin Medisan, North China Pharmaceutical Group, Chongqing Yaoyou Pharmaceutical, Hainan Star Pharmaceutical, Hebei Zhitong Biopharmaceutical, Jiangsu Jiuxu Pharmaceutical, Jiuquan Dadeli pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cobamamide for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cobamamide for Injection.
The Cobamamide for Injection market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cobamamide for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cobamamide for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Haerbin Medisan
North China Pharmaceutical Group
Chongqing Yaoyou Pharmaceutical
Hainan Star Pharmaceutical
Hebei Zhitong Biopharmaceutical
Jiangsu Jiuxu Pharmaceutical
Jiuquan Dadeli pharmaceutical
Segment by Type
0.5mg
1.0mg
1.5mg
Segment by Application
Hospital
Drug Store
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cobamamide for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cobamamide for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Cobamamide for Injection Market Overview
1.1 Product Definition
1.2 Cobamamide for Injection by Type
1.2.1 Global Cobamamide for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5mg
1.2.3 1.0mg
1.2.4 1.5mg
1.3 Cobamamide for Injection by Application
1.3.1 Global Cobamamide for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Cobamamide for Injection Market Size Estimates and Forecasts
1.4.1 Global Cobamamide for Injection Revenue 2020-2031
1.4.2 Global Cobamamide for Injection Sales 2020-2031
1.4.3 Global Cobamamide for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cobamamide for Injection Market Competition by Manufacturers
2.1 Global Cobamamide for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cobamamide for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cobamamide for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cobamamide for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cobamamide for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cobamamide for Injection, Product Type & Application
2.7 Global Key Manufacturers of Cobamamide for Injection, Date of Enter into This Industry
2.8 Global Cobamamide for Injection Market Competitive Situation and Trends
2.8.1 Global Cobamamide for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cobamamide for Injection Players Market Share by Revenue
2.8.3 Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cobamamide for Injection Market Scenario by Region
3.1 Global Cobamamide for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cobamamide for Injection Sales by Region: 2020-2031
3.2.1 Global Cobamamide for Injection Sales by Region: 2020-2025
3.2.2 Global Cobamamide for Injection Sales by Region: 2026-2031
3.3 Global Cobamamide for Injection Revenue by Region: 2020-2031
3.3.1 Global Cobamamide for Injection Revenue by Region: 2020-2025
3.3.2 Global Cobamamide for Injection Revenue by Region: 2026-2031
3.4 North America Cobamamide for Injection Market Facts & Figures by Country
3.4.1 North America Cobamamide for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cobamamide for Injection Sales by Country (2020-2031)
3.4.3 North America Cobamamide for Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cobamamide for Injection Market Facts & Figures by Country
3.5.1 Europe Cobamamide for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cobamamide for Injection Sales by Country (2020-2031)
3.5.3 Europe Cobamamide for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cobamamide for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Cobamamide for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cobamamide for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Cobamamide for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cobamamide for Injection Market Facts & Figures by Country
3.7.1 Latin America Cobamamide for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cobamamide for Injection Sales by Country (2020-2031)
3.7.3 Latin America Cobamamide for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cobamamide for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cobamamide for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cobamamide for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cobamamide for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cobamamide for Injection Sales by Type (2020-2031)
4.1.1 Global Cobamamide for Injection Sales by Type (2020-2025)
4.1.2 Global Cobamamide for Injection Sales by Type (2026-2031)
4.1.3 Global Cobamamide for Injection Sales Market Share by Type (2020-2031)
4.2 Global Cobamamide for Injection Revenue by Type (2020-2031)
4.2.1 Global Cobamamide for Injection Revenue by Type (2020-2025)
4.2.2 Global Cobamamide for Injection Revenue by Type (2026-2031)
4.2.3 Global Cobamamide for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Cobamamide for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cobamamide for Injection Sales by Application (2020-2031)
5.1.1 Global Cobamamide for Injection Sales by Application (2020-2025)
5.1.2 Global Cobamamide for Injection Sales by Application (2026-2031)
5.1.3 Global Cobamamide for Injection Sales Market Share by Application (2020-2031)
5.2 Global Cobamamide for Injection Revenue by Application (2020-2031)
5.2.1 Global Cobamamide for Injection Revenue by Application (2020-2025)
5.2.2 Global Cobamamide for Injection Revenue by Application (2026-2031)
5.2.3 Global Cobamamide for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Cobamamide for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Haerbin Medisan
6.1.1 Haerbin Medisan Company Information
6.1.2 Haerbin Medisan Description and Business Overview
6.1.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Haerbin Medisan Cobamamide for Injection Product Portfolio
6.1.5 Haerbin Medisan Recent Developments/Updates
6.2 North China Pharmaceutical Group
6.2.1 North China Pharmaceutical Group Company Information
6.2.2 North China Pharmaceutical Group Description and Business Overview
6.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 North China Pharmaceutical Group Cobamamide for Injection Product Portfolio
6.2.5 North China Pharmaceutical Group Recent Developments/Updates
6.3 Chongqing Yaoyou Pharmaceutical
6.3.1 Chongqing Yaoyou Pharmaceutical Company Information
6.3.2 Chongqing Yaoyou Pharmaceutical Description and Business Overview
6.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Portfolio
6.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
6.4 Hainan Star Pharmaceutical
6.4.1 Hainan Star Pharmaceutical Company Information
6.4.2 Hainan Star Pharmaceutical Description and Business Overview
6.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hainan Star Pharmaceutical Cobamamide for Injection Product Portfolio
6.4.5 Hainan Star Pharmaceutical Recent Developments/Updates
6.5 Hebei Zhitong Biopharmaceutical
6.5.1 Hebei Zhitong Biopharmaceutical Company Information
6.5.2 Hebei Zhitong Biopharmaceutical Description and Business Overview
6.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Portfolio
6.5.5 Hebei Zhitong Biopharmaceutical Recent Developments/Updates
6.6 Jiangsu Jiuxu Pharmaceutical
6.6.1 Jiangsu Jiuxu Pharmaceutical Company Information
6.6.2 Jiangsu Jiuxu Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Portfolio
6.6.5 Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
6.7 Jiuquan Dadeli pharmaceutical
6.7.1 Jiuquan Dadeli pharmaceutical Company Information
6.7.2 Jiuquan Dadeli pharmaceutical Description and Business Overview
6.7.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Portfolio
6.7.5 Jiuquan Dadeli pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cobamamide for Injection Industry Chain Analysis
7.2 Cobamamide for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cobamamide for Injection Production Mode & Process Analysis
7.4 Cobamamide for Injection Sales and Marketing
7.4.1 Cobamamide for Injection Sales Channels
7.4.2 Cobamamide for Injection Distributors
7.5 Cobamamide for Injection Customer Analysis
8 Cobamamide for Injection Market Dynamics
8.1 Cobamamide for Injection Industry Trends
8.2 Cobamamide for Injection Market Drivers
8.3 Cobamamide for Injection Market Challenges
8.4 Cobamamide for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cobamamide for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cobamamide for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cobamamide for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cobamamide for Injection Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Cobamamide for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cobamamide for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cobamamide for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cobamamide for Injection Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cobamamide for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cobamamide for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cobamamide for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Cobamamide for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cobamamide for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cobamamide for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cobamamide for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cobamamide for Injection Sales by Region (2020-2025) & (Kg)
Table 18. Global Cobamamide for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Cobamamide for Injection Sales by Region (2026-2031) & (Kg)
Table 20. Global Cobamamide for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Cobamamide for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cobamamide for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Cobamamide for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cobamamide for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Cobamamide for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cobamamide for Injection Sales by Country (2020-2025) & (Kg)
Table 27. North America Cobamamide for Injection Sales by Country (2026-2031) & (Kg)
Table 28. North America Cobamamide for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cobamamide for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cobamamide for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cobamamide for Injection Sales by Country (2020-2025) & (Kg)
Table 32. Europe Cobamamide for Injection Sales by Country (2026-2031) & (Kg)
Table 33. Europe Cobamamide for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cobamamide for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cobamamide for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cobamamide for Injection Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Cobamamide for Injection Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Cobamamide for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cobamamide for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cobamamide for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cobamamide for Injection Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Cobamamide for Injection Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Cobamamide for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cobamamide for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cobamamide for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cobamamide for Injection Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa Cobamamide for Injection Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa Cobamamide for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cobamamide for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cobamamide for Injection Sales (Kg) by Type (2020-2025)
Table 51. Global Cobamamide for Injection Sales (Kg) by Type (2026-2031)
Table 52. Global Cobamamide for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Cobamamide for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Cobamamide for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cobamamide for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cobamamide for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Cobamamide for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Cobamamide for Injection Price (US$/g) by Type (2020-2025)
Table 59. Global Cobamamide for Injection Price (US$/g) by Type (2026-2031)
Table 60. Global Cobamamide for Injection Sales (Kg) by Application (2020-2025)
Table 61. Global Cobamamide for Injection Sales (Kg) by Application (2026-2031)
Table 62. Global Cobamamide for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Cobamamide for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Cobamamide for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cobamamide for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cobamamide for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Cobamamide for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Cobamamide for Injection Price (US$/g) by Application (2020-2025)
Table 69. Global Cobamamide for Injection Price (US$/g) by Application (2026-2031)
Table 70. Haerbin Medisan Company Information
Table 71. Haerbin Medisan Description and Business Overview
Table 72. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. Haerbin Medisan Cobamamide for Injection Product
Table 74. Haerbin Medisan Recent Developments/Updates
Table 75. North China Pharmaceutical Group Company Information
Table 76. North China Pharmaceutical Group Description and Business Overview
Table 77. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. North China Pharmaceutical Group Cobamamide for Injection Product
Table 79. North China Pharmaceutical Group Recent Developments/Updates
Table 80. Chongqing Yaoyou Pharmaceutical Company Information
Table 81. Chongqing Yaoyou Pharmaceutical Description and Business Overview
Table 82. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product
Table 84. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 85. Hainan Star Pharmaceutical Company Information
Table 86. Hainan Star Pharmaceutical Description and Business Overview
Table 87. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. Hainan Star Pharmaceutical Cobamamide for Injection Product
Table 89. Hainan Star Pharmaceutical Recent Developments/Updates
Table 90. Hebei Zhitong Biopharmaceutical Company Information
Table 91. Hebei Zhitong Biopharmaceutical Description and Business Overview
Table 92. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product
Table 94. Hebei Zhitong Biopharmaceutical Recent Developments/Updates
Table 95. Jiangsu Jiuxu Pharmaceutical Company Information
Table 96. Jiangsu Jiuxu Pharmaceutical Description and Business Overview
Table 97. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product
Table 99. Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
Table 100. Jiuquan Dadeli pharmaceutical Company Information
Table 101. Jiuquan Dadeli pharmaceutical Description and Business Overview
Table 102. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product
Table 104. Jiuquan Dadeli pharmaceutical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Cobamamide for Injection Distributors List
Table 108. Cobamamide for Injection Customers List
Table 109. Cobamamide for Injection Market Trends
Table 110. Cobamamide for Injection Market Drivers
Table 111. Cobamamide for Injection Market Challenges
Table 112. Cobamamide for Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cobamamide for Injection
Figure 2. Global Cobamamide for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cobamamide for Injection Market Share by Type: 2024 & 2031
Figure 4. 0.5mg Product Picture
Figure 5. 1.0mg Product Picture
Figure 6. 1.5mg Product Picture
Figure 7. Global Cobamamide for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Cobamamide for Injection Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Drug Store
Figure 11. Other
Figure 12. Global Cobamamide for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cobamamide for Injection Market Size (2020-2031) & (US$ Million)
Figure 14. Global Cobamamide for Injection Sales (2020-2031) & (Kg)
Figure 15. Global Cobamamide for Injection Average Price (US$/g) & (2020-2031)
Figure 16. Cobamamide for Injection Report Years Considered
Figure 17. Cobamamide for Injection Sales Share by Manufacturers in 2024
Figure 18. Global Cobamamide for Injection Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Cobamamide for Injection Players: Market Share by Revenue in Cobamamide for Injection in 2024
Figure 20. Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Cobamamide for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Cobamamide for Injection Sales Market Share by Country (2020-2031)
Figure 23. North America Cobamamide for Injection Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Cobamamide for Injection Sales Market Share by Country (2020-2031)
Figure 27. Europe Cobamamide for Injection Revenue Market Share by Country (2020-2031)
Figure 28. Germany Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Cobamamide for Injection Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Cobamamide for Injection Revenue Market Share by Region (2020-2031)
Figure 35. China Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Cobamamide for Injection Sales Market Share by Country (2020-2031)
Figure 46. Latin America Cobamamide for Injection Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Cobamamide for Injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Cobamamide for Injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Cobamamide for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Cobamamide for Injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Cobamamide for Injection by Type (2020-2031)
Figure 57. Global Cobamamide for Injection Price (US$/g) by Type (2020-2031)
Figure 58. Global Sales Market Share of Cobamamide for Injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Cobamamide for Injection by Application (2020-2031)
Figure 60. Global Cobamamide for Injection Price (US$/g) by Application (2020-2031)
Figure 61. Cobamamide for Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
